Repository logo
 

DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.


Type

Article

Change log

Authors

Ochi, Takashi 
Blackford, Andrew N 
Coates, Julia 
Jhujh, Satpal 
Mehmood, Shahid 

Abstract

XRCC4 and XLF are two structurally related proteins that function in DNA double-strand break (DSB) repair. Here, we identify human PAXX (PAralog of XRCC4 and XLF, also called C9orf142) as a new XRCC4 superfamily member and show that its crystal structure resembles that of XRCC4. PAXX interacts directly with the DSB-repair protein Ku and is recruited to DNA-damage sites in cells. Using RNA interference and CRISPR-Cas9 to generate PAXX(-/-) cells, we demonstrate that PAXX functions with XRCC4 and XLF to mediate DSB repair and cell survival in response to DSB-inducing agents. Finally, we reveal that PAXX promotes Ku-dependent DNA ligation in vitro and assembly of core nonhomologous end-joining (NHEJ) factors on damaged chromatin in cells. These findings identify PAXX as a new component of the NHEJ machinery.

Description

Keywords

Antigens, Nuclear, Cell Line, Tumor, Crystallography, X-Ray, DNA Breaks, Double-Stranded, DNA End-Joining Repair, DNA Repair Enzymes, DNA-Binding Proteins, Humans, Ku Autoantigen, Protein Structure, Secondary, RNA Interference

Journal Title

Science

Conference Name

Journal ISSN

0036-8075
1095-9203

Volume Title

347

Publisher

American Association for the Advancement of Science (AAAS)
Sponsorship
Cancer Research Uk (None)
European Research Council (268536)
Wellcome Trust (092096/Z/10/Z)
Wellcome Trust (093167/Z/10/Z)
Cancer Research Uk (None)
Cancer Research Uk (None)
T.O. and T.L.B. are supported by the Wellcome Trust. The Jackson lab is funded by Cancer Research UK (CRUK) program grant C6/A11224, the European Research Council and the European Community Seventh Framework Programme grant agreement no. HEALTH-F2-2010- 259893 (DDResponse). Core infrastructure funding to the Jackson lab is provided by CRUK (C6946/A14492) and the Wellcome Trust (WT092096). S.P.J. receives his salary from the University of Cambridge, supplemented by CRUK. V.M.D. is a CRUK Career Development Fellow. The Draviam lab is funded by a CRUK CDA (C28598/A9787).